北交所首批2025年年报业绩预告发布： 五家预增亮眼 成本压力考验仍在

Core Viewpoint - The overall performance forecast for companies listed on the Beijing Stock Exchange indicates a positive trend, with most companies expecting profit growth, reflecting their ability to seize market opportunities and enhance competitiveness [1][2]. Group 1: Performance Forecasts - Eight companies have disclosed their performance forecasts for 2025, with five expecting profit increases, one anticipating a profit decrease, and two predicting losses [2]. - HaiNeng Technology expects a more than doubling of net profit, with an increase of 213.65% to 236.61% [2]. - Jilin Carbon Valley forecasts a net profit of 180 million to 220 million yuan, representing a year-on-year growth of 92.81% to 135.66% [1][2]. - Longzhu Technology, Wangcheng Technology, and Lintai New Materials anticipate net profit growth of approximately 50%, over 66%, and over 64%, respectively [1][2]. Group 2: Market Demand and Growth Drivers - The growth of companies is driven by both external market improvements and internal capability enhancements [3]. - The overall recovery in industry demand is a significant backdrop, with HaiNeng Technology noting a notable trend towards domestic manufacturing of high-end instruments and the gradual implementation of equipment renewal policies [3]. - Jilin Carbon Valley has experienced continuous sales growth due to the recovering carbon fiber market [3]. - Companies are enhancing their internal growth momentum through ongoing technological innovation, product upgrades, and market expansion [3][4]. Group 3: Cost Pressures and Challenges - Companies forecasting losses or declines attribute their challenges to rising fixed costs, reduced specific revenues, and ongoing adjustments in their respective sectors [5][6]. - Hualing Co. cites significant increases in depreciation expenses due to fixed assets entering full depreciation in 2025 and rising employee compensation costs [5][6]. - Geobijia mentions a decline in overall gross margin due to a lower sales proportion of high-margin specialty glass products and reduced government subsidies compared to the previous year [6]. - YingTai Bio has narrowed its losses significantly through focused product strategies and cost control, but still faces challenges from investment losses and a sluggish market for intermediates [6].